These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 20354454

  • 1. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ, Choe G, Jheon S, Sung SW, Lee CT, Chung JH.
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B, Muley T, Meister M, Dienemann H, Christensen IJ, Santoni-Rugiu E, Lærum OD, Ploug M.
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.
    Kinoshita T, Ohtsuka T, Yotsukura M, Asakura K, Goto T, Kamiyama I, Otake S, Tajima A, Emoto K, Hayashi Y, Kohno M.
    J Thorac Oncol; 2015 Apr; 10(4):619-28. PubMed ID: 25634009
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X, Wang D.
    BMC Cancer; 2016 Nov 10; 16(1):876. PubMed ID: 27832750
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.
    Cho HJ, Kim HR, Park YS, Kim YH, Kim DK, Park SI.
    Surg Oncol; 2015 Dec 10; 24(4):329-34. PubMed ID: 26690822
    [Abstract] [Full Text] [Related]

  • 18. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K, Ye Z, Li Z, Dang Y, Chen X, Huang N, Bao C, Gan T, Yang L, Chen G.
    World J Surg Oncol; 2016 Feb 09; 14(1):34. PubMed ID: 26860827
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.
    Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I.
    Br J Cancer; 2003 Jan 27; 88(2):231-6. PubMed ID: 12610508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.